cyclosporine and Carcinoma, Medullary

cyclosporine has been researched along with Carcinoma, Medullary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gibassier, J; Leclech, G; Lucas, C; Massart, C; Pourquier, P; Raoul, M; Robert, J1
Gibassier, J; Lucas, C; Massart, C; Pourquier, P; Robert, J1

Reviews

1 review(s) available for cyclosporine and Carcinoma, Medullary

ArticleYear
[Expression of the MDR1 gene in five human cell lines of medullary thyroid cancer and reversion of the resistance to doxorubicine by ciclosporin A and verapamil].
    Bulletin du cancer, 1996, Volume: 83, Issue:1

    Topics: Antineoplastic Agents; Carcinoma, Medullary; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Humans; Thyroid Neoplasms; Tumor Cells, Cultured; Verapamil

1996

Other Studies

1 other study(ies) available for cyclosporine and Carcinoma, Medullary

ArticleYear
Cyclosporin A, verapamil and S9788 reverse doxorubicin resistance in a human medullary thyroid carcinoma cell line.
    Anti-cancer drugs, 1995, Volume: 6, Issue:1

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Medullary; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Drug Synergism; Glutathione; Glutathione Transferase; Humans; Neoplasm Proteins; Piperidines; Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Thyroid Neoplasms; Triazines; Verapamil

1995